Tramadol

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Tramadol is a generic pain reliever drug used in the United States. The US brand names are: ConZip, FusePaq Synapryn, rybix ODT, Ryzolt, Ultram and Ultram ER. Unlike traditional opioids, tramadol exerts its effects through a combination of serotonergic and opioid mechanisms, and is thought to be less habit-forming. At high doses it also has noradrenergic effects. Sleep disturbances are commonly reported if taken too close to bedtime, and with the extended-release versions.

It is used for moderate to moderately severe pain, and pain after surgery. The extended release or long acting form is used on chronic pain.[1]

A three-year study showed a correlation between tramadol consumption and seizure occurrence.[2]

Notable studies

"In our study, it was seen that seizures occurred both at therapeutic and supratherapeutic ranges without history of epilepsy."[2]

"Conclusion: In conclusion, the neurotoxicity of tramadol commonly manifests as generalized tonic-clonic seizures, most frequently within 24 hours after tramadol intake, and was more common in subjects concomitantly consuming alcohol, illicit drugs, anti-psychotics, or anti-depressants."[2]

See also

Learn more

References

  1. Tramadol - Mayo Clinic
  2. 2.0 2.1 2.2 2.3 Boostani, Reza; Derakhshan, Siavash (2012). "Tramadol induced seizure: A 3-year study". Caspian Journal of Internal Medicine. 3 (3): 484–487. ISSN 2008-6164. PMC 3755854. PMID 24009919.